Zafrira Avnur
Director/Board Member at CathWorks Ltd.
Zafrira Avnur active positions
| Companies | Position | Start | End |
|---|---|---|---|
Lyndra Therapeutics, Inc.
 Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | Director/Board Member | - | - |
PhysIQ, Inc.
 PhysIQ, Inc. Packaged SoftwareTechnology Services PhysIQ, Inc. provides proprietary predictive analytics for human physiology. It designs, develops and commercializes predictive analytics technologies to monitor the health of complex systems. The company was founded by Matt R. Pipke and Gary W. Conkright in 1999 and is headquartered in Naperville, IL. | Director/Board Member | 2017-07-25 | - |
CathWorks Ltd.
 CathWorks Ltd. Medical SpecialtiesHealth Technology CathWorks Ltd. develops medical devices for the interventional cardiology market. Its technology is based on processing visual information and automatic multi-layered algorithms. The company was founded by Guy Lavi and Ifat Lavi in 2013 and is headquartered in Raanana, Israel. | Director/Board Member | - | - |
Enclear Therapies, Inc.
 Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | Director/Board Member | 2020-02-18 | - |
Raziel Therapeutics RT Ltd.
 Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Director/Board Member | 2019-12-09 | - |
Volastra Therapeutics, Inc.
 Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Director/Board Member | - | - |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Director/Board Member | 2021-03-10 | - |
20/20 HealthCare Partners LLC
 20/20 HealthCare Partners LLC Investment ManagersFinance 20/20 HealthCare Partners LLC (20/20 HealthCare Partners) is a venture capital firm founded in 2005 by Hillel Bachrach. The firm is headquartered in Auburndale, Massachusetts. | Consultant / Advisor | - | - |
Quark Venture, Inc.
 Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | Private Equity Investor | 2016-09-30 | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Career history of Zafrira Avnur
Former positions of Zafrira Avnur
| Companies | Position | Start | End |
|---|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Zafrira Avnur
| Ben-Gurion University of the Negev | Graduate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Statistics
International
| United States | 13 |
| Israel | 7 |
| Switzerland | 2 |
Operational
| Director/Board Member | 15 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 14 |
| Technology Services | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
| KEROS THERAPEUTICS, INC. | Health Technology |
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 15 |
|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Microbion Corp.
 Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | Health Technology |
CalciMedica, Inc. (US)
CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Health Technology |
PhysIQ, Inc.
PhysIQ, Inc. Packaged SoftwareTechnology Services PhysIQ, Inc. provides proprietary predictive analytics for human physiology. It designs, develops and commercializes predictive analytics technologies to monitor the health of complex systems. The company was founded by Matt R. Pipke and Gary W. Conkright in 1999 and is headquartered in Naperville, IL. | Technology Services |
20/20 HealthCare Partners LLC
20/20 HealthCare Partners LLC Investment ManagersFinance 20/20 HealthCare Partners LLC (20/20 HealthCare Partners) is a venture capital firm founded in 2005 by Hillel Bachrach. The firm is headquartered in Auburndale, Massachusetts. | Finance |
Biscayne Neurotherapeutics, Inc.
 Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Biscayne Neurotherapeutics, Inc. engages in the development of novel treatments for epilepsy, pain and other central nervous system (CNS) disorders. The company was founded by Samuel J. Reich on November 15, 2011 and is headquartered in Miami, FL. | Health Technology |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Health Technology |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Health Technology |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | Technology Services |
CathWorks Ltd.
CathWorks Ltd. Medical SpecialtiesHealth Technology CathWorks Ltd. develops medical devices for the interventional cardiology market. Its technology is based on processing visual information and automatic multi-layered algorithms. The company was founded by Guy Lavi and Ifat Lavi in 2013 and is headquartered in Raanana, Israel. | Health Technology |
Pi Therapeutics Ltd.
 Pi Therapeutics Ltd. BiotechnologyHealth Technology Pi Therapeutics Ltd. develops a proprietary cancer drug. The company was founded by Ori Kalid in March 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
Quark Venture, Inc.
Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | Finance |
Enclear Therapies, Inc.
Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | Health Technology |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Health Technology |
Nemdx, Inc.
 Nemdx, Inc. Packaged SoftwareTechnology Services Nemdx, Inc. is a medical diagnostic platform that focuses on revealing critical information on protein function in neurodegenerative diseases. | Technology Services |
- Stock Market
- Insiders
- Zafrira Avnur
- Experience
